Commitments and Contingencies (Tables)

9 Months Ended

Sep. 30, 2024

Commitments And Contingencies [Line Items]

Schedule Of Royalty Liability Account Roll Forward

The following table shows the activity within the Royalty Liability account during the nine months ended September 30, 2024 as well as the effective interest rate (dollars in thousands):

Balance, January 1, 2024	$	145,810
Amortization of deferred transaction costs		172
Non-cash interest expense on liability for sale of future royalties		12,548
Royalty revenue earned by or payable to Sagard		(9,635	)
Balance, September 30, 2024	$	148,895
Effective interest rate	8.8% – 11.5%

Schedule of Lease Term and Discount Rate

Financing liability information was as follows (dollars in thousands):

	September 30, 2024		December 31, 2023
Weighted average remaining lease term (in years)		17.1		17.8

Lease information was as follows (dollars in thousands):

	September 30, 2024			December 31, 2023
Operating lease right-of-use assets(1)	$	13,637		$	4,685
Operating lease liability-current(2)	$	2,431		$	1,423
Operating lease liability-long-term		12,167			3,925
Total	$	14,598		$	5,348
Weighted average remaining lease term (in years)		7.3			3.7
Weighted average discount rate		7.25	%		7.25	%

_________________________

(1)Operating right-of-use assets related to vehicles, offices and the manufacturing facility for V-Go are included in other assets in the condensed consolidated balance sheets.

(2)Operating lease liability – current is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

Summary of Lease Information

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Interest expense on financing liability	$	2,470	$	2,459	$	7,361	$	7,332

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
Operating lease costs	$	719	$	422	$	1,417	$	1,253
Variable lease costs		104		48		122		97
Cash paid		860		268		1,407		825

Summary of Remaining Financing Liability Payments

The Company's remaining financing liability payments were as follows (in thousands):

	September 30, 2024
Remainder of 2024	$	2,532
2025		10,269
2026		10,533
2027		10,849
2028		11,174
Thereafter		177,278
Total		222,635
Interest payments		(116,113	)
Debt issuance costs		(2,519	)
Total financing liability	$	104,003

Summary of Financing Lease Information

Financing lease information was as follows (dollars in thousands):

	September 30, 2024
Financing lease right-of-use asset(1)	$	219
Financing lease liability-current(2)	$	52
Financing lease liability-long-term		171
Total	$	223
Weighted average remaining lease term (in years)		4.7
Weighted average discount rate		7.25	%

_________________________

(1)Financing right-of-use asset is included in other assets in the condensed consolidated balance sheets.

(2)Financing lease liability – current is included in accrued expenses and other current liabilities in the condensed consolidated balance sheets.

Remaining Purchase Commitments and Estimated Capacity Fee Liability Requirements

The Company's remaining purchase commitments and estimated capacity fee liability as of September 30, 2024 were as follows (€ in millions):

	September 30, 2024
	Remaining Purchase Commitments		Estimated Capacity Fees
2025		—		1.5
2026(1)		4.2		2.0
2027		6.0		1.0
2028		6.0		1.0
2029		6.0		1.0
2030		6.0		1.0
2031		8.0		0.5
2032		8.0		0.5
2033		8.0		0.5
2034		4.4		0.5
Total		56.6		9.5

_________________________

If there is a delay in the availability of insulin with FDA approved inclusion bodies and supply does not begin in 2026 as currently expected, the Company will incur a capacity fee of €750,000 per quarter that the product is not available for purchase.

Schedule of Future Minimum Office And Vehicle Lease Payments

The Company's future minimum office and vehicle lease payments were as follows (in thousands):

	September 30, 2024
Remainder of 2024	$	784
2025		3,157
2026		2,579
2027		2,540
2028		2,087
Thereafter		7,721
Total		18,868
Interest expense		(4,270	)
Total operating lease liability	$	14,598

Audio Visual Equipment

Commitments And Contingencies [Line Items]

Summary of Remaining Financing Liability Payments

The Company's remaining financing lease payments were as follows (in thousands):

	September 30, 2024
Remainder of 2024	$	27
2025		54
2026		54
2027		54
2028		54
Thereafter		23
Total		266
Interest payments		(43	)
Total financing liability	$	223